Wang SY - Search Results

1

Multicenter phase II study of capecitabine combined with nedaplatin for recurrent and metastatic nasopharyngeal carcinoma patients after failure of cisplatin-based chemotherapy.

Peng PJ, Ou XQ, Chen ZB, Liao H, Peng YL, Wang SY, Zhang HY, Lin Z. Peng PJ, et al. Among authors: wang sy. Cancer Chemother Pharmacol. 2013 Aug;72(2):323-8. doi: 10.1007/s00280-013-2203-0. Epub 2013 Jun 1. Cancer Chemother Pharmacol. 2013. PMID: 23728706 Clinical Trial.

2

Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial.

Chen L, Hu CS, Chen XZ, Hu GQ, Cheng ZB, Sun Y, Li WX, Chen YY, Xie FY, Liang SB, Chen Y, Xu TT, Li B, Long GX, Wang SY, Zheng BM, Guo Y, Sun Y, Mao YP, Tang LL, Chen YM, Liu MZ, Ma J. Chen L, et al. Among authors: wang sy. Lancet Oncol. 2012 Feb;13(2):163-71. doi: 10.1016/S1470-2045(11)70320-5. Epub 2011 Dec 7. Lancet Oncol. 2012. PMID: 22154591 Clinical Trial.

3

Safety and efficacy of S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy: multi-institutional retrospective analysis.

Peng PJ, Cheng H, Ou XQ, Zeng LJ, Wu X, Liu YM, Lin Z, Tang YN, Wang SY, Zhang HY, Chen ZB. Peng PJ, et al. Among authors: wang sy. Drug Des Devel Ther. 2014 Aug 14;8:1083-7. doi: 10.2147/DDDT.S67592. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 25152614 Free PMC article.

4

Significant prognostic impact of chemoradiotherapy-induced hemoglobin decrease on treatment outcomes of nasopharyngeal carcinoma.

Liang XX, Li Q, Su Z, Lan XW, Ouyang PY, Mao YP, Shi DB, Deng WG, Cheng ZB, Wang SY, Xie FY. Liang XX, et al. Among authors: wang sy. J Cancer. 2015 Apr 2;6(6):502-10. doi: 10.7150/jca.11403. eCollection 2015. J Cancer. 2015. PMID: 26000040 Free PMC article.

5

Randomized, Multicenter Study of Gefitinib Dose-escalation in Advanced Non-small-cell Lung Cancer Patients Achieved Stable Disease after One-month Gefitinib Treatment.

Xue C, Hong S, Li N, Feng W, Jia J, Peng J, Lin D, Cao X, Wang S, Zhang W, Zhang H, Dong W, Zhang L. Xue C, et al. Sci Rep. 2015 Jul 28;5:10648. doi: 10.1038/srep10648. Sci Rep. 2015. PMID: 26216071 Free PMC article. Clinical Trial.

6

Subdivision of M category for nasopharyngeal carcinoma with synchronous metastasis: time to expand the M categorization system.

Shen LJ, Wang SY, Xie GF, Zeng Q, Chen C, Dong AN, Huang ZM, Pan CC, Xia YF, Wu PH. Shen LJ, et al. Among authors: wang sy. Chin J Cancer. 2015 Aug 12;34(10):450-8. doi: 10.1186/s40880-015-0031-9. Chin J Cancer. 2015. PMID: 26264052 Free PMC article.

7

Phase II trial of docetaxel combined with nedaplatin for patients with recurrent and metastatic nasopharyngeal carcinoma.

Peng PJ, Lv BJ, Tang C, Liao H, Lin Z, Liu YM, Wang ZH, Wang SY, Cheng ZB. Peng PJ, et al. Among authors: wang zh, wang sy. Drug Des Devel Ther. 2015 Dec 10;9:6401-5. doi: 10.2147/DDDT.S95946. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26677316 Free PMC article. Clinical Trial.

8

Phase I trial of nedaplatin chemotherapy concurrent with radiotherapy for untreated locoregionally advanced nasopharyngeal carcinoma.

Liang Z, Wang S, Lin Z, Feng S, Cheng Z, Yang Y, Kuang Y, Fidelis C, Ullah S, Li F. Liang Z, et al. Cancer Chemother Pharmacol. 2016 Mar;77(3):643-51. doi: 10.1007/s00280-016-2971-4. Epub 2016 Jan 30. Cancer Chemother Pharmacol. 2016. PMID: 26831498 Clinical Trial.

9

Image-based Multilevel Subdivision of M1 Category in TNM Staging System for Metastatic Nasopharyngeal Carcinoma.

Shen L, Li W, Wang S, Xie G, Zeng Q, Chen C, Shi F, Zhang Y, Wu M, Shu W, Pan C, Xia Y, Wu P. Shen L, et al. Radiology. 2016 Sep;280(3):805-14. doi: 10.1148/radiol.2016151344. Epub 2016 Mar 29. Radiology. 2016. PMID: 27023116

10

Phase II study of gemcitabine plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy.

Peng P, Ou X, Liao H, Liu Y, Wang S, Cheng Z, Lin Z. Peng P, et al. Ther Adv Med Oncol. 2016 May;8(3):153-9. doi: 10.1177/1758834016637592. Epub 2016 Mar 11. Ther Adv Med Oncol. 2016. PMID: 27239233 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,861 results

Search Page

Filters